Expanding Chronic Therapy Adherence with a Single Programmable Device

Session details:

Chronic and injection-based therapies carry strong clinical evidence, but poor compliance and access remain barriers to achieving their full potential. DARE-IDDS is a subcutaneous device with wireless communication and control, storing and releasing 100+ discrete doses over months to years converting long-term or chronic injection therapy into a single outpatient procedure. Clinical and preclinical case studies will demonstrate technical capabilities and how the platform's dosing flexibility and adherence monitoring unlock value for patients, providers, and commercial partners.